Combining new and old drugs improves survival for soft-tissue cancer patients

Adding a novel monoclonal antibody therapy to traditional chemotherapy increased median survival by nearly a year in patients with advanced sarcoma, a lethal soft-tissue cancer. Findings from a multicenter clinical trial of the combination therapy, led by researchers at Columbia University Medical Center and NewYork-Presbyterian, represent the first appreciable improvement in sarcoma outcomes in decades. … Continue reading Combining new and old drugs improves survival for soft-tissue cancer patients

Advertisements

Many skin cancer patients still too likely to sunburn

A recent study by researchers at Johns Hopkins concludes that a substantial number of people with a history of the most frequent kind of nonmelanoma skin cancers still get sunburned at the same rate as those without a previous history, probably because they are not using sun-protective methods the right way or in the right amounts. … Continue reading Many skin cancer patients still too likely to sunburn